ClassID:

94090

C07D207/50 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom Nitrogen atoms

Recent Application in this class:
#1
20250388531
2025-12-25

SUBSTITUTED TETRACYCLINE COMPOUNDS

#2
20250361205
2025-11-27

ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF

#3
20250339395
2025-11-06

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

#4
20250320216
2025-10-16

PHOSPHODIESTERASE INHIBITORS AND USES THEREOF

#5
20250051286
2025-02-13

SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF

#6
20240343730
2024-10-17

2-PHENYL-3,4-DIHYDROPYRROLO[2,1 -F] [1,2,4]TRIAZINONE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS AND USES THEREOF

#7
20240208926
2024-06-27

NEW PROCESS FOR THE SYNTHESIS OF 5-{5-CHLORO-2-[(3S)-3-[(MORPHOLIN-4-YL)METHYL]-3,4-DIHYDROISOQUINOLINE-2(1H)- CARBONYL]PHENYL}-1,2-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID DERIVATIVES AND ITS APPLICATION FOR THE PRODUCTION OF PHARMACEUTICAL COMPOUNDS

#8
20230303611
2023-09-28

SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE

#9
20230167067
2023-06-01

PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES

#10
20230159441
2023-05-25

ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF

#11
20220373541
2022-11-24

Tri-functional crosslinking reagents

#12
20220331282
2022-10-20

Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations

#13
20220257551
2022-08-18

AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND SODIUM CATIONS

#14
20220169655
2022-06-02

2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof

#15
20220064106
2022-03-03

NITRIC OXIDE DONORS

#16
20210395189
2021-12-23

SUBSTITUTED TETRACYCLINE COMPOUNDS

#17
20210361610
2021-11-25

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

#18
20210347762
2021-11-11

Carbocyclic prolinamide derivatives

#19
20210147403
2021-05-20

SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES

#20
20200385362
2020-12-10

Carbocyclic prolinamide derivatives

#21
20200239478
2020-07-30

2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof

#22
20200115374
2020-04-16

Modulators of indoleamine 2,3-dioxygenase

#23
20200016110
2020-01-16

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

#24
20200016109
2020-01-16

Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations

#25
20200002284
2020-01-02

Photoredox-catalyzed direct C-H functionalization of arenes

#26
20190374498
2019-12-12

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

#27
20190374497
2019-12-12

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

#28
20190345099
2019-11-14

Nitric oxide donors

#29
20190337955
2019-11-07

Activation of carbonyl beta-carbons for chemical transformations

#30
20190263795
2019-08-29

Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases

#31
20190202810
2019-07-04

Carbocyclic prolinamide derivatives

#32
20190177272
2019-06-13

2-pyrrolidine phenylhydrazides antibacterial agents

#33
20190106388
2019-04-11

Derivatives of pyrrole-2,5-diones having a fungicidal activity, their agronomical compositions and use thereof

#34
20190077753
2019-03-14

Methods of preparing tecovirimat

#35
20180344679
2018-12-06

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

#36
20180328922
2018-11-15

Tri-functional crosslinking reagents

#37
20180319803
2018-11-08

Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-D]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)

#38
20180312513
2018-11-01

2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof

#39
20180297949
2018-10-18

Methods of preparing tecovirimat

#40
20180206491
2018-07-26

SUBSTITUTED CYCLIC ARYL AND HETEROARYL CARBOXYLIC ACID HYDRAZIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS

#41
20180148414
2018-05-31

Photoredox-catalyzed direct C—H functionalization of arenes

#42
20180086705
2018-03-29

Methods of preparing Tecovirimat

#43
20170267633
2017-09-21

Crystalline arylalkylamine compound and process for producing the same

#44
20170137412
2017-05-18

Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases

#45
20170088517
2017-03-30

Methods of preparing Tecovirimat

#46
20160297758
2016-10-13

Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

#47
20160287582
2016-10-06

Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases

#48
20160251309
2016-09-01

Bicyclic compounds

#49
20160200679
2016-07-14

Crystalline 4-(3S-(1R-(1-napthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acid

#50
20160192651
2016-07-07

Pesticide

#51
20150322010
2015-11-12

Methods of preparing Tecovirimat

#52
20150315126
2015-11-05

Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A

#53
20150152048
2015-06-04

Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases

#54
20150141378
2015-05-21

Nitroxyl progenitor compounds and methods of use

#55
20150057322
2015-02-26

Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations

#56
20150018564
2015-01-15

Amide compound or salt thereof, biofilm inhibitor, biofilm remover and disinfectant containing the same

#57
20140336227
2014-11-13

3-AMINO LACTAMS AS ANTI-INFLAMMATORY AGENTS

#58
20140336158
2014-11-13

NKantagonists

#59
20140200250
2014-07-17

Anti-cancer agents

#60
20140187531
2014-07-03

Apoptosis promoters

#61
20140135295
2014-05-15

NONOate derivatives and uses thereof

#62
20130102779
2013-04-25

Substituted tetracycline compounds

#63
20130045949
2013-02-21

Anti-cancer agents

#64
20130023503
2013-01-24

NK1 antagonists

#65
20120296094
2012-11-22

Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same

#66
20120190700
2012-07-26

4-amino-N-hydroxy-benzamides for the treatment of cancer

#67
20120184737
2012-07-19

Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support

#68
20120178789
2012-07-12

Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use

#69
20110256129
2011-10-20

Apoptosis promoters

#70
20110201666
2011-08-18

COMPOUNDS FROM MYCELIUM OF ANTRODIA CINNAMOMEA AND USE THEREOF

#71
20110178091
2011-07-21

Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders

#72
20110144112
2011-06-16

Apoptosis promoters

#73
20110098468
2011-04-28

NKantagonists

#74
20110092514
2011-04-21

Compounds with anti-cancer activity

#75
20100305072
2010-12-02

Substituted tetracycline compounds

#76
20100286227
2010-11-11

Compounds from mycelium of and use thereof

#77
20100248355
2010-09-30

METHODS FOR GENERATING HIGH TITER HELPER-FREE PREPARATIONS OF RELEASED RECOMBINANT AAV VECTORS

#78
20100087442
2010-04-08

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#79
20100081806
2010-04-01

Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support

#80
20090286994
2009-11-19

Process for Synthesizing Nitramine Compounds

#81
20090281067
2009-11-12

Nitroxyl progenitor compounds and methods of use

#82
20090264650
2009-10-22

Prophylactic/Therapeutic Agent for Diabetes

#83
20090227567
2009-09-10

METHODS OF TREATING P38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS

#84
20090203739
2009-08-13

Anti-Inflammatory Agents

#85
20090186859
2009-07-23

DIAZENIUMDIOLATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, COMPOSITIONS THEREOF, AND RELATED METHODS

#86
20090156585
2009-06-18

Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations

#87
20090118509
2009-05-07

PREPARATION OF [2-METHYL-5-PHENYL-3-(PIPERAZIN-1-YLMETHYL)] PYRROLE DERIVATIVES

#88
20090111809
2009-04-30

Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1

#89
20090068120
2009-03-12

Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same

#90
20090042965
2009-02-12

Inhibitors for steroid response elements and related methods

#91
20080281095
2008-11-13

Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support

#92
20080275057
2008-11-06

Compounds with anti-cancer activity

#93
20080206812
2008-08-28

Methods for generating high titer helper-free preparations of released recombinant AAV vectors

#94
20080176854
2008-07-24

Nitro-Substituted Phenyl-Piperazine Compounds, Their Preparation and Use in Medicaments

#95
20070155803
2007-07-05

Protease inhibitors

#96
20070072860
2007-03-29

Apoptosis promoters

#97
20070015787
2007-01-18

Apoptosis promoters

#98
20060229449
2006-10-12

Method for preparing pyrrolotriazine compounds via in situ amination of pyrroles

#99
20060199815
2006-09-07

NKantagonists

#100
20060178490
2006-08-10

Catalysts containing N-pyrrolyl substituted nitrogen donors

#101
20060111303
2006-05-25

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#102
20060052588
2006-03-09

Novel nitrosation polymer in organic synthesis

#103
20060030708
2006-02-09

Methods for the preparation of pyrrolotriazine compounds

#104
20050266567
2005-12-01

Methods for generating high titer helper-free preparations of released recombinant AAV vectors

#105
20050124001
2005-06-09

Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support

#106
20050107462
2005-05-19

Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors

#107
20050090381
2005-04-28

Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors

#108
20050054856
2005-03-10

Catalysts containing N-pyrrolyl substituted nitrogen donors